Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 15 Breast Neoplasms 14 Sarcoma 11 Squamous Cell Carcinoma of Head and Neck 10 Glioblastoma 10 Esophageal Neoplasms 9 Rectal Neoplasms 8 Stomach Neoplasms 7 Urinary Bladder Neoplasms 6 Neoplasms 6 Carcinoma, Hepatocellular 6 Pancreatic Neoplasms 5 Colorectal Neoplasms 5 Brain Neoplasms 5 Oropharyngeal Neoplasms 4 Lung Neoplasms 4 Hypopharyngeal Neoplasms 4 Head and Neck Neoplasms 4 Glioma 4 Colonic Neoplasms 4 Recurrence 3 Prostatic Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Neoplasm Metastasis 3 Mouth Neoplasms 3 Melanoma 3 Astrocytoma 3 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Skin Neoplasms 2

Interventions

Doxorubicin 7 pembrolizumab 5 Radiotherapy 5 Specimen Handling 4 Radiation 4 Magnetic Resonance Spectroscopy 4 palbociclib 3 eribulin 3 Ifosfamide 3 Biopsy 3 pazopanib 2 brigimadlin 2 abemaciclib 2 Immunoglobulin G 2 zimberelimab 1 toripalimab 1 talimogene laherparepvec 1 silmitasertib 1 selinexor 1 ribociclib 1 peposertib 1 pemigatinib 1 olaratumab 1 olaparib 1 mirdametinib 1 liposomal doxorubicin 1 lenvatinib 1 enzalutamide 1 durvalumab 1 cemiplimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Liposarcoma × Surgical Procedures, Operative × 1 year × Clear all

NCT04031677 2026-05-22

STRASS2

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡